Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Diversified Healthcare Trust (NASDAQ: DHC) closed at $2.43 up 0.83% from its previous closing price of $2.41. In other words, the price has increased by $0.83 from its previous closing price. On the day, 0.66 million shares were traded. DHC stock price reached its highest trading level at $2.44 during the session, while it also had its lowest trading level at $2.37.
Ratios:
For a deeper understanding of Diversified Healthcare Trust’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 1.21.
Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 14 ’23 when PORTNOY ADAM D. bought 2,000,000 shares for $3.07 per share. The transaction valued at 6,132,600 led to the insider holds 23,250,019 shares of the business.
PORTNOY ADAM D. bought 1,992,259 shares of DHC for $6,026,783 on Jun 13 ’23. The Director now owns 21,250,019 shares after completing the transaction at $3.03 per share. On Jun 12 ’23, another insider, PORTNOY ADAM D., who serves as the Director of the company, bought 2,011,256 shares for $2.87 each. As a result, the insider paid 5,778,540 and bolstered with 19,257,760 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 584215744 and an Enterprise Value of 3178874624. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23 while its Price-to-Book (P/B) ratio in mrq is 0.25. Its current Enterprise Value per Revenue stands at 2.254 whereas that against EBITDA is 15.98.
Stock Price History:
The Beta on a monthly basis for DHC is 2.06, which has changed by 1.7 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $3.96, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -9.64%, while the 200-Day Moving Average is calculated to be -5.68%.
Shares Statistics:
For the past three months, DHC has traded an average of 1.12M shares per day and 678510 over the past ten days. A total of 240.42M shares are outstanding, with a floating share count of 215.61M. Insiders hold about 10.32% of the company’s shares, while institutions hold 76.09% stake in the company. Shares short for DHC as of 1711584000 were 7267664 with a Short Ratio of 6.49, compared to 1709164800 on 6177024. Therefore, it implies a Short% of Shares Outstanding of 7267664 and a Short% of Float of 3.35.
Dividends & Splits
According to the company, the forward annual dividend rate for DHC is 0.04, from 0.04 in the trailing year. The stock’s 5-year Average Dividend Yield is 5.15.
Earnings Estimates
Currently, 1 analysts are dedicated to thoroughly evaluating and rating the performance of Diversified Healthcare Trust (DHC) in the stock market.On average, analysts expect EPS of $-0.28 for the current quarter, with a high estimate of $-0.28 and a low estimate of $-0.28, while EPS last year was $-0.27. The consensus estimate for the next quarter is $-0.27, with high estimates of $-0.27 and low estimates of $-0.27.
Analysts are recommending an EPS of between $-1.05 and $-1.05 for the fiscal current year, implying an average EPS of $-1.05. EPS for the following year is $-0.76, with 1 analysts recommending between $-0.76 and $-0.76.
Revenue Estimates
A total of 3 analysts believe the company’s revenue will be $370.65M this quarter.It ranges from a high estimate of $372.9M to a low estimate of $367.62M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $337.61M, an estimated increase of 9.80% from the year-ago figure.
A total of 3 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.53B, while the lowest revenue estimate was $1.5B, resulting in an average revenue estimate of $1.51B. In the same quarter a year ago, actual revenue was $1.41B, up 7.40% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $1.61B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.58B. The average revenue growth estimate for next year is up 6.30% from the average revenue estimate for this year.
